Open-label study of the short-term effects of memantine on FDG-PET in frontotemporal dementia
Tiffany W Chow1–6, Ariel Graff-Guerrero4,6, Nicolaas PLG Verhoeff2–4,7, Malcolm A Binns3,8, David F Tang-Wai5,9, Morris Freedman1,3,5, Mario Masellis5,10, Sandra E Black3,5,10, Alan A Wilson4,6, Sylvain Houle4,6, Bruce G Pollock4,61Division of Neurology, 2Department of Ps...
Guardado en:
Autores principales: | Chow TW, Graff-Guerrero A, Verhoeff NP, Binns MA, Tang-Wai DF, Freedman M, Masellis M, Black SE, Wilson AA, Houle S, Pollock BG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8907b36c3b844e2b984d0c77c9064601 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Memantine for the treatment of frontotemporal dementia: a meta-analysis
por: Kishi T, et al.
Publicado: (2015) -
Reference cluster normalization improves detection of frontotemporal lobar degeneration by means of FDG-PET.
por: Juergen Dukart, et al.
Publicado: (2013) -
Psychosis in behavioral variant frontotemporal dementia
por: Gossink FT, et al.
Publicado: (2017) -
Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS
por: E. Taskesen, et al.
Publicado: (2017) -
In vivo exploration of synaptic projections in frontotemporal dementia
por: Eric Salmon, et al.
Publicado: (2021)